@LeeSwaggart@triumph1796 3 years later, still sucks. And dont bother calling investor relations. They wont give you any answers or call you back. Total SCAM!
@mvmntin i see the price is starting to reflect what this company is truly worth. Half a penny is still generous in my opinion. They havent closed one aquisition theyve claimed in the last 6 years. SCAM!!
@neilmck37597308 They also have 105 employees not including directors ceos, csos, advisors, ect. Here a legitimate plausible breakdown of the average monthly expenditures. They arent running a gas station.
❤️ IT’S OFFICIAL! WE’RE MEETING PRESIDENT TRUMP TOMORROW! 🇺🇸
Braelyn and I have been invited to attend tomorrow’s rally for Darline Graham in Clemson! We’ll be seated in the VIP section AND have the opportunity to meet President Trump in the “click line”!
Ben is cutting his work trip short, and we’re hoping he’ll make it home in time to join us!
We’ll have only seconds with the President, but I intend to make every one of them count. I’ll also be bringing information for him and his staff about Braelyn, DCVax-L, and the barriers American patients face trying to access promising treatments developed right here in the United States.
This is an extraordinary opportunity, but we’re hoping it can become something even bigger.
PLEASE HELP US GET THE ATTENTION OF THE WHITE HOUSE PRESS TEAM! 🙏
We would love the opportunity for a longer conversation with President Trump or his administration about how we can make these treatments accessible to American patients.
Please SHARE, REPOST, and TAG anyone who might help get Braelyn’s story in front of the right people!
Three years ago, Braelyn was given just months to live. Today she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE!
Her story deserves to be heard. And so do the stories of countless other patients fighting for access to promising treatments.
@realDonaldTrump@DrOzCMS@WhiteHouse
#DCVaxForBraelyn #DCVax #PresidentTrump
@TomBaxers And if he has no nefarious intentions, he will have no problem ignoring people he doesnt know if he decides not to respond. Stop giving stock holders that much credit. Thats a rediculous notion.
@TomBaxers Asking a man for an action of decency is not hurting anything. If he cannot publicly recuse himself, thats telling and is not going to be influenced by supporters on X. If his plan is nefarious, it has been long before any emails.
@maxstradamus21 Ypu really think i jabe that kind of power over his or the MHRA's decision making? Yeah hes gonna go on a vandetta all bc of me. If he doesnt respond with intent of recusal, nothing different happens and the lack of response just shows what was gping to happen anyway.
@KennethPar49290 Right, its more of the indirect influence we are worried about as he will surely speak with the people making the decision about approval.
@DWpaMont He signed an opinion response in the JAMA 2022 article that was negative towards the trial design. Hes also advised GSK, who has a phase 3 glioblastoma drug in the process. So thats a major conflict of interest.
$nwbo Anthony Chalmers has publicly criticized DCVax-L and has disclosed paid pharma relationships, including GSK, while leading a UK brain-cancer review. To avoid even the appearance of bias, he should recuse himself from any NWBO/DCVax-L discussions!!
@jonjazzpics Another "Doc" showing his ass at how stupid they've become due to big pharma's influence on everything they've learned. No suprise. Most doctors have egos the size of Texas. You cant break that out of them because that would mean they have been lied to. Tough pill to swallow.